Repligen | RGEN - Interessi Passivi Sul Debito





Interessi Passivi Sul Debito Cambiamento Data
Agilent USD 29M 4M 2026-06
Align Technology USD 9.96M 3.02M 2026-06
Bio Techne USD 3.6M 1.19M 2026-06
BioMarin Pharmaceutical USD 55.63M 7.67M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
Bruker USD 17.8M 9.7M 2026-06
Charles River Laboratories USD 30.34M 3.6M 2026-06
Danaher USD 135M 28M 2026-09
Dentsply International USD 22M 2M 2026-06
General Electric Aerospace USD 231M 265M 2026-09
Henry Schein USD 42M 1000K 2026-09
Illumina USD 24M 0 2026-09
IQVIA Holdings USD 203M 6M 2026-09
Mettler Toledo International USD 17.25M 239K 2026-06
Myriad Genetics USD 4.4M 600K 2025-12
OraSure Technologies 1.67M 1.13M 2025-12
Pacific Biosciences Of California USD 1.74M 1000 2025-12
Pfizer USD 662M 5M 2026-09
Repligen USD 5.71M 49K 2026-09
Revvity USD 22.99M 1.73M 2026-06
Standard Biotools USD 5K 5K 2025-12
Thermo Fisher Scientific USD 417M 63M 2026-09
Waters USD 53M 2M 2026-09
West Pharmaceutical Services USD 3.8M 1.2M 2026-09